BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25630683)

  • 1. Reduced Activity of Sphingosine-1-Phosphate Lyase Induces Podocyte-related Glomerular Proteinuria, Skin Irritation, and Platelet Activation.
    Schümann J; Grevot A; Ledieu D; Wolf A; Schubart A; Piaia A; Sutter E; Côté S; Beerli C; Pognan F; Billich A; Moulin P; Walker UJ
    Toxicol Pathol; 2015 Jul; 43(5):694-703. PubMed ID: 25630683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of sphingosine-1-phosphate lyase rescues sphingosine kinase-1-knockout phenotype following murine cardiac arrest.
    Gorshkova IA; Wang H; Orbelyan GA; Goya J; Natarajan V; Beiser DG; Vanden Hoek TL; Berdyshev EV
    Life Sci; 2013 Sep; 93(9-11):359-66. PubMed ID: 23892195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of sphingosine 1-phosphate lyase activates human keratinocyte differentiation and attenuates psoriasis in mice.
    Jeon S; Song J; Lee D; Kim GT; Park SH; Shin DY; Shin KO; Park K; Shim SM; Park TS
    J Lipid Res; 2020 Jan; 61(1):20-32. PubMed ID: 31690639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients.
    Schwab SR; Pereira JP; Matloubian M; Xu Y; Huang Y; Cyster JG
    Science; 2005 Sep; 309(5741):1735-9. PubMed ID: 16151014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a link between histone deacetylation and Ca²+ homoeostasis in sphingosine-1-phosphate lyase-deficient fibroblasts.
    Ihlefeld K; Claas RF; Koch A; Pfeilschifter JM; Meyer Zu Heringdorf D
    Biochem J; 2012 Nov; 447(3):457-64. PubMed ID: 22908849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of sphingosine-1-phosphate lyase for the treatment of autoimmune disorders.
    Bagdanoff JT; Donoviel MS; Nouraldeen A; Tarver J; Fu Q; Carlsen M; Jessop TC; Zhang H; Hazelwood J; Nguyen H; Baugh SD; Gardyan M; Terranova KM; Barbosa J; Yan J; Bednarz M; Layek S; Courtney LF; Taylor J; Digeorge-Foushee AM; Gopinathan S; Bruce D; Smith T; Moran L; O'Neill E; Kramer J; Lai Z; Kimball SD; Liu Q; Sun W; Yu S; Swaffield J; Wilson A; Main A; Carson KG; Oravecz T; Augeri DJ
    J Med Chem; 2009 Jul; 52(13):3941-53. PubMed ID: 19489538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S1P lyase in thymic perivascular spaces promotes egress of mature thymocytes via up-regulation of S1P receptor 1.
    Maeda Y; Yagi H; Takemoto K; Utsumi H; Fukunari A; Sugahara K; Masuko T; Chiba K
    Int Immunol; 2014 May; 26(5):245-55. PubMed ID: 24343820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting sphingosine-1-phosphate lyase as an anabolic therapy for bone loss.
    Weske S; Vaidya M; Reese A; von Wnuck Lipinski K; Keul P; Bayer JK; Fischer JW; Flögel U; Nelsen J; Epple M; Scatena M; Schwedhelm E; Dörr M; Völzke H; Moritz E; Hannemann A; Rauch BH; Gräler MH; Heusch G; Levkau B
    Nat Med; 2018 May; 24(5):667-678. PubMed ID: 29662200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein tyrosine phosphatase 1B inhibition protects against podocyte injury and proteinuria.
    Kumagai T; Baldwin C; Aoudjit L; Nezvitsky L; Robins R; Jiang R; Takano T
    Am J Pathol; 2014 Aug; 184(8):2211-24. PubMed ID: 24951831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lyase to live by: sphingosine phosphate lyase as a therapeutic target.
    Kumar A; Saba JD
    Expert Opin Ther Targets; 2009 Aug; 13(8):1013-25. PubMed ID: 19534571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural sphingosine 1-phosphate accumulation activates microglia and links impaired autophagy and inflammation.
    Karunakaran I; Alam S; Jayagopi S; Frohberger SJ; Hansen JN; Kuehlwein J; Hölbling BV; Schumak B; Hübner MP; Gräler MH; Halle A; van Echten-Deckert G
    Glia; 2019 Oct; 67(10):1859-1872. PubMed ID: 31231866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
    Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
    J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S1P-lyase independent clearance of extracellular sphingosine 1-phosphate after dephosphorylation and cellular uptake.
    Peest U; Sensken SC; Andréani P; Hänel P; Van Veldhoven PP; Gräler MH
    J Cell Biochem; 2008 Jun; 104(3):756-72. PubMed ID: 18172856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orally active 7-substituted (4-benzylphthalazin-1-yl)-2-methylpiperazin-1-yl]nicotinonitriles as active-site inhibitors of sphingosine 1-phosphate lyase for the treatment of multiple sclerosis.
    Weiler S; Braendlin N; Beerli C; Bergsdorf C; Schubart A; Srinivas H; Oberhauser B; Billich A
    J Med Chem; 2014 Jun; 57(12):5074-84. PubMed ID: 24809814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingolipid-to-glycerophospholipid conversion in SPL-null cells implies the existence of an alternative isozyme.
    Ikeda M; Kihara A; Kariya Y; Lee YM; Igarashi Y
    Biochem Biophys Res Commun; 2005 Apr; 329(2):474-9. PubMed ID: 15737611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assay to measure the secretion of sphingosine-1-phosphate from cells induced by S1P lyase inhibitors.
    Loetscher E; Schneider K; Beerli C; Billich A
    Biochem Biophys Res Commun; 2013 Apr; 433(3):345-8. PubMed ID: 23499842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of S1P Lyase Expression in Human Podocytes Causes a Reduction in Nephrin Expression That Involves PKCδ Activation.
    Imeri F; Stepanovska Tanturovska B; Manaila R; Pavenstädt H; Pfeilschifter J; Huwiler A
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incomplete inhibition of sphingosine 1-phosphate lyase modulates immune system function yet prevents early lethality and non-lymphoid lesions.
    Vogel P; Donoviel MS; Read R; Hansen GM; Hazlewood J; Anderson SJ; Sun W; Swaffield J; Oravecz T
    PLoS One; 2009; 4(1):e4112. PubMed ID: 19119317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingosine-1-phosphate lyase SPL is an endoplasmic reticulum-resident, integral membrane protein with the pyridoxal 5'-phosphate binding domain exposed to the cytosol.
    Ikeda M; Kihara A; Igarashi Y
    Biochem Biophys Res Commun; 2004 Dec; 325(1):338-43. PubMed ID: 15522238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Products by the sphingosine kinase/sphingosine 1-phosphate (S1P) lyase pathway but not S1P stimulate mitogenesis.
    Kariya Y; Kihara A; Ikeda M; Kikuchi F; Nakamura S; Hashimoto S; Choi CH; Lee YM; Igarashi Y
    Genes Cells; 2005 Jun; 10(6):605-15. PubMed ID: 15938718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.